Inotrem
BioTech/Drugs - Paris, Île-de-France, FR
Inotrem Employees
Jean-Jacques Garaud
Executive Vice-President, Scientific and Medical Affairs
Inotrem Senior Management
Inotrem Details
Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases.
Inotrem Technologies
E-commerce Platforms
Woo Commerce
Email Providers
Outlook
Load Balancers
Apache
Tag Management
Google Tag Manager
Other
Microsoft Office 365
CSS and JavaScript Libraries
Bootstrap Framework